M. Eileen Dolan

M. Eileen Dolan

University of Chicago

H-index: 85

North America-United States

About M. Eileen Dolan

M. Eileen Dolan, With an exceptional h-index of 85 and a recent h-index of 37 (since 2020), a distinguished researcher at University of Chicago, specializes in the field of Pharmacogenomics and Experimental Therapeutics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of pain and adverse health outcomes on long-term US testicular cancer survivors

Behavioral Outcomes and Neurodevelopmental Disorders Among Children of Women With Epilepsy

Updates to the Alliance of Genome Resources Central Infrastructure

Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN).

The gene ontology knowledgebase in 2023

Patient-reported functional impairment due to hearing loss and tinnitus after cisplatin-based chemotherapy

M. Eileen Dolan Information

University

Position

Professor of Medicine

Citations(all)

27131

Citations(since 2020)

6664

Cited By

26841

hIndex(all)

85

hIndex(since 2020)

37

i10Index(all)

295

i10Index(since 2020)

133

Email

University Profile Page

Google Scholar

M. Eileen Dolan Skills & Research Interests

Pharmacogenomics and Experimental Therapeutics

Top articles of M. Eileen Dolan

Title

Journal

Author(s)

Publication Date

Impact of pain and adverse health outcomes on long-term US testicular cancer survivors

JNCI: Journal of the National Cancer Institute

Paul C Dinh Jr

Patrick O Monahan

Sophie D Fosså

Howard D Sesso

Darren R Feldman

...

2024/3/1

Behavioral Outcomes and Neurodevelopmental Disorders Among Children of Women With Epilepsy

JAMA neurology

Morris J Cohen

Kimford J Meador

David W Loring

Abigail G Matthews

Carrie Brown

...

2024/1/1

Updates to the Alliance of Genome Resources Central Infrastructure

bioRxiv

Alliance of Genome Resources Consortium

2023/11/22

Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer

Cancer Medicine

Mohammad Shahbazi

Xindi Zhang

Paul C Dinh

Victoria A Sanchez

Matthew R Trendowski

...

2023/2

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

Journal of Cancer Survivorship

Victoria A Sanchez

Paul C Dinh Jr

Jennessa Rooker

Patrick O Monahan

Sandra K Althouse

...

2023/2

The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN).

Swetha Nakshatri

Paul C Dinh

Darren R Feldman

Robert James Hamilton

David J Vaughn

...

2023/6/1

The gene ontology knowledgebase in 2023

Suzi A Aleksander

James Balhoff

Seth Carbon

J Michael Cherry

Harold J Drabkin

...

2023/5/2

Patient-reported functional impairment due to hearing loss and tinnitus after cisplatin-based chemotherapy

Journal of Clinical Oncology

Victoria A Sanchez

Megan M Shuey

Paul C Dinh Jr

Patrick O Monahan

Sophie D Fosså

...

2023/4/20

Chicago EYES on Cancer: Fostering diversity in biomedicine through cancer research training for students and teachers

Journal of STEM outreach

Megan A Mekinda

Steven R Rogg

Christopher G Peña

Michelle L Domecki

Kathleen H Goss

...

2022

Impact of cisplatin-induced hearing loss (CIHL) on patient-reported social and emotional functioning.

Victoria Sanchez

Megan Shuey

Paul C Dinh

Patrick Monahan

Howard D Sesso

...

2022/6/1

Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment.

Swetha Nakshatri

Megan Shuey

Mohammad Shahbazi

Matthew Trendowski

Paul C Dinh

...

2022/6/1

The Obstetrical Care and Delivery Experience of Women with Epilepsy in the MONEAD Study

American journal of perinatology

Thomas F McElrath

Maurice Druzin

Linda J Van Marter

Ryan C May

Carrie Brown

...

2022/12/31

Cisplatin-induced tinnitus (CIS-TINN) and patient-reported outcomes in adult-onset cancer survivors.

Megan Shuey

Victoria Sanchez

Paul C Dinh

Patrick O Monahan

Howard D Sesso

...

2022/6/1

Ototoxicity after cisplatin-based chemotherapy: factors associated with discrepancies between patient-reported outcomes and audiometric assessments

Ear and hearing

Shirin Ardeshirrouhanifard

Sophie D Fossa

Robert Huddart

Patrick O Monahan

Chunkit Fung

...

2022/5/1

The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: an observational cohort study

EBioMedicine

Ana I Hernandez Cordero

Chen Xi Yang

Julia Yang

Xuan Li

Steve Horvath

...

2022/9/1

Antiseizure medication concentrations during pregnancy: results from the maternal outcomes and neurodevelopmental effects of antiepileptic drugs (MONEAD) study

JAMA neurology

Page B Pennell

Ashwin Karanam

Kimford J Meador

Elizabeth Gerard

Laura Kalayjian

...

2022/4/1

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Cancer Medicine

Xindi Zhang

Matthew R Trendowski

Emma Wilkinson

Mohammad Shahbazi

Paul C Dinh

...

2022/7

Hearing loss after cisplatin-based chemotherapy: Patient-reported outcomes versus audiometric assessments.

Shirin Ardeshirrouhanifard

Sophie Fosså

Robert A Huddart

Patrick O Monahan

Chunkit Fung

...

2021/5/20

Gynecologic cancer treatment toxicities and relationships with the vaginal microbiome

Gynecologic Oncology

Despina Tsementzi

Zahra A Barandouzi

Mary Dolan

Patel Pretesh

Joseph Shelton

...

2021/8/1

Comparisons of depression, sexual function, and quality of life between women with gynecological cancers and race-matched healthy controls

Cancer Nursing

Jinbing Bai

Sarah M Belcher

Rebecca Meador

Gaea Daniel

Joseph Shelton

...

2021/3/1

See List of Professors in M. Eileen Dolan University(University of Chicago)